Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-31

Clinical Trial Update: To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing haemodynamic effects of a single-dose atracurium with or without reversal on extubation and evaluating residual paralysis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atracurium (atracurium besilate)

Snippet

Sponsor: Ziauddin University | Conditions: Tachycardia, Hypertension | Phase 1, Phase 2 | Status: COMPLETED